about
Treatment for osteoporosis in people with ß-thalassaemiaTreatment for osteoporosis in people with ß-thalassaemiaImpaired gallbladder motility and delayed orocecal transit contribute to pigment gallstone and biliary sludge formation in beta-thalassemia major adults.A case of successful management with splenectomy of intractable ascites due to congenital dyserythropoietic anemia type II-induced cirrhosis.Association between serum ferritin level and diastolic cardiac function in patients with major β-thalassemia.Prevalence and specificities of red cell alloantibodies in transfusion-dependent beta thalassemia patients in YazdExjade(R) (deferasirox, ICL670) in the treatment of chronic iron overload associated with blood transfusion.Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma.Toward optimizing the use of deferasirox: potential benefits of combined use with deferoxamineFetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of {beta}-Thalassemia and Sickle-Cell Anemia.Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.Neridronate improves bone mineral density and reduces back pain in β-thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel-arm, open-label study.Role of pharmacogenetics on deferasirox AUC and efficacy.Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.Endocrine and metabolic disorders in β-thalassemiamajor patients.Resolution of alloimmunization and refractory autoimmune hemolytic anemia in a multi-transfused beta-thalassemia major patient.A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.Self-reported level of and factors influencing the compliance to desferrioxamine therapy in multitransfused thalassaemias.Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).RBC alloimmunization and double alloantibodies in thalassemic patients.Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.Short-term toxicity study of ST-20 (NSC-741804) by oral gavage in Sprague-Dawley rats.
P2860
Q24186036-9A763A6A-4AB2-4CA2-99BD-5014F2A6F63EQ24200472-AEF4C8D4-29CE-4067-9D42-12F4CB4A50E7Q30402581-55424F39-0C8F-4296-A00C-C52E36B40B56Q33788525-106C566D-5E7E-4A25-B97A-0FDD3125835BQ35763360-013DF632-5642-44ED-A0A5-C6141493DDD1Q35763368-55DD3BAA-BECA-45E4-86F7-0B2E1CFCC3D9Q35919222-EE290B0B-F88C-4877-B98A-1ADC6E855AB2Q36478403-131DF1E7-58C3-4B40-99E9-4CC7EFC4A542Q36498403-1133EE83-6F04-47BC-9318-BACEB2BE667DQ37309900-DAFD8B6A-CB58-4C10-9A90-7BE700C72175Q37809337-1B804852-9CED-4B8A-953F-A8E7F6BB0622Q38471926-F86A1889-BAD0-414C-B527-09A7429CA624Q39865051-8DE8F052-A30E-4D4D-9C19-27EF77D49247Q40746113-927FD85B-A903-4AA3-891F-29AC19795E65Q41836924-180F07B7-5266-4D69-B635-586FC70DB180Q42028283-444E15B2-6C67-462F-9DE4-9B6273356302Q42224585-66E7D304-21D5-463C-914A-E1DA9EC17EE8Q44144195-82662EF7-C13D-4247-8F2D-84B7178300ACQ45384567-7606C4F0-15F4-44C9-ABB7-256EE9DAA953Q50462438-656369A0-9826-4FBA-9EFE-56131BF8F60CQ50527741-FC0C1C78-E7D1-4EE4-9F9B-DA14DBF6A477Q50537208-88B9B52D-9F8C-4DDD-8435-8999358FBFF2
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical management of beta-thalassemia major.
@ast
Clinical management of beta-thalassemia major.
@en
Clinical management of beta-thalassemia major.
@nl
type
label
Clinical management of beta-thalassemia major.
@ast
Clinical management of beta-thalassemia major.
@en
Clinical management of beta-thalassemia major.
@nl
prefLabel
Clinical management of beta-thalassemia major.
@ast
Clinical management of beta-thalassemia major.
@en
Clinical management of beta-thalassemia major.
@nl
P1476
Clinical management of beta-thalassemia major.
@en
P2093
P304
P356
10.1016/S0037-1963(01)90029-0
P577
2001-10-01T00:00:00Z